Taysha Gene Therapies
TSHA
#5638
Rank
ยฃ0.88 B
Marketcap
ยฃ3.07
Share price
-5.79%
Change (1 day)
105.96%
Change (1 year)

Earnings for Taysha Gene Therapies (TSHA)

Earnings in 2025 (TTM): -ยฃ75.56 Million

According to Taysha Gene Therapies's latest financial reports the company's current earnings are ยฃ6.31 Million. In 2024 the company made an earning of -ยฃ67.34 Million, an increase over its 2023 earnings that were of -ยฃ84.13 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Taysha Gene Therapies from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ75.56 Million12.21%
2024 -ยฃ67.34 Million-19.96%
2023 -ยฃ84.13 Million-33.06%
2022 -ยฃ0.13 Billion-4.51%
2021 -ยฃ0.14 Billion190.82%
2020 -ยฃ45.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 48.13%๐Ÿ‡บ๐Ÿ‡ธ USA